Evonik Industries (FRA:EVK) has been assigned a €30.00 ($34.88) target price by Sanford C. Bernstein in a report released on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Sanford C. Bernstein’s target price would indicate a potential upside of 31.75% from the stock’s current price.
Several other equities analysts have also commented on EVK. Credit Suisse Group set a €25.00 ($29.07) target price on shares of Evonik Industries and gave the company a “neutral” rating in a report on Thursday. Deutsche Bank set a €38.00 ($44.19) target price on shares of Evonik Industries and gave the company a “buy” rating in a report on Thursday, October 3rd. Warburg Research set a €36.00 ($41.86) target price on shares of Evonik Industries and gave the company a “buy” rating in a report on Thursday, August 1st. Bank of America set a €24.00 ($27.91) target price on shares of Evonik Industries and gave the company a “sell” rating in a report on Friday, September 20th. Finally, Independent Research set a €25.00 ($29.07) price target on shares of Evonik Industries and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of €28.93 ($33.64).
EVK stock opened at €22.77 ($26.48) on Friday. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34). The company’s 50-day moving average price is €22.76 and its two-hundred day moving average price is €24.53.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: Stock Split
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.